URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Wojciech Zareba

Concepts (600)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Electrocardiography
119
1994
719
15.010
Why?
Long QT Syndrome
88
1994
346
14.410
Why?
Defibrillators, Implantable
86
2000
373
13.660
Why?
Myocardial Infarction
82
1994
630
11.350
Why?
Heart Rate
63
1995
449
9.690
Why?
Death, Sudden, Cardiac
67
1994
246
8.170
Why?
Heart Failure
36
2004
337
8.030
Why?
Heart Conduction System
28
1994
144
7.130
Why?
Tachycardia, Ventricular
37
1994
146
6.740
Why?
Electrocardiography, Ambulatory
37
1990
91
6.720
Why?
Ventricular Dysfunction, Left
30
2001
149
6.600
Why?
Arrhythmias, Cardiac
29
1994
224
5.050
Why?
Risk Assessment
64
2001
808
4.670
Why?
Cardiac Resynchronization Therapy
15
2010
71
4.070
Why?
Humans
301
1986
35000
3.840
Why?
Male
227
1986
18870
3.680
Why?
Risk Factors
98
1994
2172
3.630
Why?
Female
218
1986
19061
3.450
Why?
Arrhythmogenic Right Ventricular Dysplasia
11
2003
18
3.280
Why?
Middle Aged
139
1986
9461
3.050
Why?
Mutation
31
1995
1183
2.980
Why?
Ether-A-Go-Go Potassium Channels
13
2002
48
2.940
Why?
Genetic Predisposition to Disease
26
1999
306
2.920
Why?
Diagnosis, Computer-Assisted
8
2005
64
2.830
Why?
Electric Countershock
15
2004
88
2.760
Why?
Ventricular Fibrillation
15
2003
89
2.700
Why?
Aged
105
1986
6986
2.690
Why?
Coronary Disease
18
1990
247
2.680
Why?
Coronary Artery Disease
11
2003
85
2.620
Why?
Survival Analysis
41
1997
575
2.520
Why?
Proportional Hazards Models
56
1998
398
2.430
Why?
Stroke Volume
26
2002
140
2.410
Why?
Myocardial Ischemia
15
1994
112
2.400
Why?
KCNQ1 Potassium Channel
15
2002
63
2.390
Why?
Treatment Outcome
52
2001
2487
2.340
Why?
Adrenergic beta-Antagonists
27
1998
152
2.230
Why?
Prognosis
45
1994
1030
2.210
Why?
Adult
108
1986
10906
2.170
Why?
Cardiac Pacing, Artificial
8
2005
151
2.030
Why?
Atrial Fibrillation
10
2003
110
2.030
Why?
Anti-Arrhythmia Agents
10
1994
80
2.010
Why?
Follow-Up Studies
54
1994
1757
1.990
Why?
Genotype
37
1995
455
1.970
Why?
Cardiology
5
1991
51
1.920
Why?
Heart Arrest
23
1994
131
1.770
Why?
Heart Diseases
8
1991
132
1.750
Why?
Sodium Channels
10
1998
117
1.730
Why?
Sotalol
6
2003
16
1.670
Why?
Polymorphism, Genetic
9
2001
191
1.660
Why?
Tachycardia, Sinus
3
1997
8
1.660
Why?
Time Factors
36
1990
3047
1.540
Why?
Pacemaker, Artificial
7
2004
158
1.520
Why?
Syncope
22
1994
94
1.510
Why?
Romano-Ward Syndrome
7
2007
30
1.500
Why?
Torsades de Pointes
8
1997
32
1.490
Why?
Coronary Artery Bypass
4
2003
105
1.450
Why?
Algorithms
10
2003
518
1.440
Why?
Signal Processing, Computer-Assisted
13
1995
102
1.440
Why?
Recurrence
28
1997
656
1.410
Why?
Multivariate Analysis
23
1995
487
1.390
Why?
Ventricular Premature Complexes
7
2003
18
1.380
Why?
Randomized Controlled Trials as Topic
7
2003
400
1.370
Why?
Periodicals as Topic
2
2011
77
1.360
Why?
Ventricular Function, Left
7
2005
88
1.300
Why?
Phenotype
27
1995
727
1.290
Why?
Potassium Channels, Voltage-Gated
6
2002
34
1.280
Why?
Echocardiography
14
2000
202
1.270
Why?
Cardiomyopathy, Dilated
7
1994
33
1.270
Why?
Survival Rate
25
2000
584
1.240
Why?
Predictive Value of Tests
19
1994
579
1.220
Why?
Cardiovascular Diseases
10
2001
250
1.190
Why?
Severity of Illness Index
21
2001
878
1.150
Why?
Adolescent
45
1986
4513
1.130
Why?
Sex Factors
16
1995
561
1.120
Why?
Potassium Channels
8
2002
128
1.110
Why?
Kaplan-Meier Estimate
21
2007
190
1.100
Why?
Prospective Studies
31
1999
1606
1.090
Why?
Sensitivity and Specificity
20
1998
866
1.090
Why?
Ventricular Function
4
1995
36
1.060
Why?
Multicenter Studies as Topic
8
2001
126
1.050
Why?
Magnetic Resonance Imaging
4
2006
928
1.040
Why?
Retrospective Studies
23
1998
2167
1.040
Why?
Heart Ventricles
12
1990
192
1.020
Why?
Cardiac Resynchronization Therapy Devices
3
2011
12
0.990
Why?
Journal Impact Factor
2
2011
5
0.980
Why?
Bundle-Branch Block
6
2003
44
0.980
Why?
Aza Compounds
3
2008
21
0.960
Why?
Angiotensin-Converting Enzyme Inhibitors
4
2002
48
0.960
Why?
Quinolines
3
2008
42
0.940
Why?
Environmental Exposure
4
2004
200
0.930
Why?
Biological Markers
16
2000
532
0.920
Why?
Anti-Infective Agents
3
2008
74
0.910
Why?
Air Pollutants
6
2001
180
0.910
Why?
Mutation, Missense
5
2002
81
0.900
Why?
Heterozygote
10
1998
120
0.900
Why?
Cause of Death
10
2001
155
0.880
Why?
Registries
21
1998
203
0.870
Why?
Practice Guidelines as Topic
7
2007
288
0.860
Why?
Telemedicine
3
2005
40
0.860
Why?
Child
32
1994
3897
0.840
Why?
Angina, Unstable
6
1994
33
0.830
Why?
Societies, Medical
5
2001
132
0.810
Why?
European Continental Ancestry Group
5
2006
225
0.800
Why?
Glomerular Filtration Rate
2
2006
82
0.790
Why?
Carbon
4
2004
79
0.790
Why?
Diabetes Mellitus, Type 2
4
2001
208
0.780
Why?
Muscle Proteins
2
2008
131
0.780
Why?
Research Design
5
2002
326
0.760
Why?
Cholesterol Ester Transfer Proteins
2
2007
14
0.760
Why?
Cohort Studies
14
1994
912
0.750
Why?
Heart Failure, Diastolic
1
2011
1
0.750
Why?
United States
22
1991
2511
0.750
Why?
Exercise
5
2001
155
0.730
Why?
Lipoproteins
4
2001
99
0.730
Why?
Young Adult
17
2008
1013
0.720
Why?
C-Reactive Protein
10
2002
118
0.710
Why?
Reproducibility of Results
15
1998
859
0.700
Why?
Chi-Square Distribution
16
1999
320
0.700
Why?
Sequence Deletion
2
2007
123
0.690
Why?
Child, Preschool
22
1995
2452
0.690
Why?
Posture
1
2010
107
0.680
Why?
von Willebrand Factor
4
1999
59
0.680
Why?
African Continental Ancestry Group
3
2006
116
0.680
Why?
Hospitalization
7
2004
354
0.660
Why?
DNA
2
2011
831
0.660
Why?
Air Pollution
4
2005
44
0.650
Why?
Terminology as Topic
2
2006
104
0.650
Why?
Lipids
10
1999
164
0.650
Why?
Consensus Development Conferences as Topic
1
2008
7
0.640
Why?
Incidence
13
2006
644
0.640
Why?
Cation Transport Proteins
3
2002
18
0.640
Why?
Ventricular Dysfunction
1
2008
7
0.640
Why?
Obesity
3
2000
301
0.630
Why?
Kidney Diseases
2
2009
167
0.630
Why?
Angioplasty, Balloon, Coronary
2
2005
60
0.620
Why?
Hypertension
3
2003
285
0.620
Why?
Smoking
3
2000
387
0.610
Why?
Infant
17
1995
2102
0.600
Why?
Physicians
2
2005
143
0.580
Why?
Age Factors
12
1995
1060
0.580
Why?
Hyperglycemia
1
2008
89
0.570
Why?
Cardiomyopathies
5
2003
75
0.560
Why?
Angiotensinogen
1
2006
7
0.550
Why?
Risk
9
2004
343
0.550
Why?
Regression Analysis
11
1994
489
0.550
Why?
Models, Biological
2
2011
982
0.540
Why?
Polymorphism, Single Nucleotide
5
2007
87
0.540
Why?
Probability
10
2001
289
0.540
Why?
Particulate Matter
5
2006
45
0.540
Why?
Attitude of Health Personnel
2
2005
267
0.530
Why?
Comorbidity
9
1999
365
0.530
Why?
Mental Health
1
2007
83
0.530
Why?
Heart
7
1995
228
0.520
Why?
Angioplasty, Balloon
1
2006
66
0.520
Why?
Diabetes Mellitus
2
2001
162
0.510
Why?
Sex Distribution
9
2003
142
0.510
Why?
Trans-Activators
3
2002
343
0.510
Why?
Aged, 80 and over
14
2004
2423
0.510
Why?
Models, Economic
1
2005
27
0.510
Why?
Cholesterol, HDL
5
2003
52
0.500
Why?
Circadian Rhythm
2
2004
80
0.500
Why?
Gonadal Steroid Hormones
1
2005
35
0.490
Why?
Public Opinion
1
2005
17
0.490
Why?
Health Care Costs
1
2005
99
0.470
Why?
Critical Illness
1
2005
50
0.470
Why?
Choice Behavior
1
2005
44
0.470
Why?
Tachycardia, Supraventricular
3
1990
19
0.460
Why?
Ion Channels
9
1995
149
0.450
Why?
Sequence Analysis, Protein
1
2003
14
0.450
Why?
DNA-Binding Proteins
3
2002
661
0.450
Why?
Steroids
1
2004
54
0.450
Why?
Statistics, Nonparametric
11
2001
251
0.440
Why?
Reference Values
6
1999
427
0.440
Why?
Case-Control Studies
9
1997
587
0.440
Why?
Jervell-Lange Nielsen Syndrome
3
2002
9
0.430
Why?
Pirenzepine
1
2003
1
0.430
Why?
Sequence Alignment
1
2003
197
0.420
Why?
Haloperidol
1
2003
38
0.420
Why?
Myocardium
3
2006
284
0.420
Why?
Myocardial Contraction
3
2011
107
0.420
Why?
Ventricular Remodeling
3
2010
34
0.410
Why?
Particle Size
9
2002
195
0.410
Why?
Autonomic Nervous System
5
2001
69
0.410
Why?
Logistic Models
11
2000
581
0.390
Why?
Drug Approval
1
2002
19
0.390
Why?
Antipsychotic Agents
1
2003
96
0.380
Why?
Age Distribution
8
2003
201
0.380
Why?
Electrophysiology
9
1994
243
0.380
Why?
Inflammation
6
2002
518
0.380
Why?
Patient Selection
4
2008
197
0.370
Why?
Disease Progression
7
2002
496
0.370
Why?
Blood Urea Nitrogen
4
2005
42
0.350
Why?
Analysis of Variance
6
1994
705
0.340
Why?
Monitoring, Physiologic
2
2010
94
0.340
Why?
Spain
4
2008
19
0.340
Why?
Mortality
3
1997
87
0.340
Why?
Metabolic Syndrome X
3
2003
56
0.340
Why?
Odds Ratio
8
1995
301
0.340
Why?
Cholesterol
3
1997
130
0.330
Why?
Ion Channel Gating
2
2011
126
0.330
Why?
Myocardial Revascularization
2
2006
21
0.320
Why?
Biopsy
2
2010
359
0.320
Why?
Recovery of Function
2
2009
102
0.320
Why?
Equipment Design
5
2006
244
0.310
Why?
Hospital Mortality
3
2006
131
0.310
Why?
Blood Pressure
4
2007
446
0.310
Why?
Up-Regulation
3
2006
344
0.310
Why?
Baroreflex
3
2004
22
0.310
Why?
Connexin 43
2
2006
34
0.300
Why?
Diphenhydramine
1
1997
9
0.300
Why?
Histamine H1 Antagonists
1
1997
15
0.300
Why?
DNA Mutational Analysis
5
2002
185
0.300
Why?
Clinical Trials as Topic
6
2002
664
0.290
Why?
Evidence-Based Medicine
2
2009
197
0.290
Why?
ROC Curve
5
1998
119
0.290
Why?
Asthma
3
1999
282
0.280
Why?
Death
2
2003
22
0.280
Why?
Equipment Failure
4
2008
70
0.280
Why?
KCNQ Potassium Channels
4
2002
17
0.280
Why?
New York
6
2001
1191
0.280
Why?
Women's Health
1
1997
58
0.270
Why?
Fibrin Fibrinogen Degradation Products
4
1999
47
0.270
Why?
Phospholipases A
2
2006
37
0.270
Why?
Body Mass Index
3
2000
207
0.270
Why?
Angina Pectoris
4
1994
48
0.270
Why?
Plasminogen Activator Inhibitor 1
3
1999
39
0.260
Why?
Inhalation Exposure
2
2007
86
0.260
Why?
Hemodynamics
2
2002
263
0.260
Why?
Genetic Testing
5
2003
92
0.250
Why?
Pregnancy Complications, Cardiovascular
3
1998
35
0.250
Why?
Databases, Factual
2
2005
147
0.250
Why?
Infant, Newborn
8
2007
1772
0.240
Why?
Prevalence
3
2003
530
0.240
Why?
Coronary Vessels
2
2004
126
0.240
Why?
Therapy, Computer-Assisted
2
2008
12
0.230
Why?
Canada
3
2007
75
0.230
Why?
Blood Glucose
3
2001
451
0.230
Why?
Flecainide
2
2001
12
0.220
Why?
Testosterone
2
2004
151
0.220
Why?
Confidence Intervals
3
2007
155
0.220
Why?
Dose-Response Relationship, Drug
3
1997
1085
0.220
Why?
Convalescence
3
1994
19
0.220
Why?
Pedigree
3
2002
225
0.220
Why?
Enzyme-Linked Immunosorbent Assay
3
1999
459
0.220
Why?
Patient Admission
2
2007
77
0.220
Why?
Thrombosis
4
1999
196
0.210
Why?
Ventricular Dysfunction, Right
2
2009
17
0.210
Why?
International Cooperation
2
1998
64
0.210
Why?
Age of Onset
3
2001
120
0.210
Why?
Combined Modality Therapy
4
1986
459
0.210
Why?
Japan
2
2007
28
0.210
Why?
Remote Sensing Technology
1
2012
2
0.200
Why?
Serum Amyloid A Protein
4
2002
22
0.200
Why?
Cross-Over Studies
2
2009
117
0.200
Why?
Emotions
2
2001
87
0.200
Why?
Ventricular Function, Right
3
2005
26
0.200
Why?
Thrombospondins
1
2011
11
0.200
Why?
Defibrillators
1
2011
5
0.200
Why?
Arteritis
1
2011
14
0.200
Why?
Israel
2
2007
30
0.190
Why?
Survivors
2
2006
112
0.190
Why?
Ventricular Outflow Obstruction
1
2011
11
0.190
Why?
Oxidants, Photochemical
1
2011
28
0.190
Why?
Coronary Care Units
1
2011
16
0.190
Why?
Referral and Consultation
2
2010
188
0.190
Why?
Genetic Variation
2
2008
148
0.190
Why?
Hemostasis
2
1999
61
0.190
Why?
Guideline Adherence
2
2008
72
0.190
Why?
Drug Therapy, Combination
2
2008
375
0.190
Why?
Cardiotoxins
1
2011
3
0.190
Why?
Menopause
1
2011
40
0.190
Why?
Neuromuscular Nondepolarizing Agents
1
2011
14
0.190
Why?
Cooperative Behavior
1
2012
95
0.190
Why?
Heart Defects, Congenital
1
2011
88
0.180
Why?
Tachycardia, Paroxysmal
1
2010
10
0.180
Why?
Enalapril
1
2010
7
0.180
Why?
Ozone
1
2011
84
0.180
Why?
Spironolactone
1
2010
12
0.180
Why?
Diagnosis, Differential
3
2000
855
0.180
Why?
Language
1
2011
26
0.180
Why?
Databases, Genetic
1
2010
26
0.180
Why?
Heart Function Tests
3
2001
29
0.180
Why?
Pattern Recognition, Automated
2
2005
26
0.180
Why?
Drug Evaluation, Preclinical
1
2011
72
0.180
Why?
Gene Frequency
2
2006
83
0.180
Why?
Electrodes, Implanted
1
2011
53
0.180
Why?
Primary Prevention
2
2007
52
0.180
Why?
Societies, Nursing
1
2010
1
0.180
Why?
Cardiology Service, Hospital
1
2010
2
0.180
Why?
Heavy Ions
1
2010
2
0.180
Why?
Guidelines as Topic
1
2011
87
0.180
Why?
Adrenergic beta-Agonists
2
1999
52
0.170
Why?
Forecasting
3
1998
172
0.170
Why?
Reference Standards
1
2010
44
0.170
Why?
Hypertriglyceridemia
2
2006
23
0.170
Why?
Physician's Practice Patterns
2
2008
223
0.170
Why?
Life Change Events
1
2010
95
0.170
Why?
Internet
2
2007
92
0.170
Why?
Hospital Units
1
2010
18
0.170
Why?
Disease-Free Survival
3
2001
191
0.170
Why?
Blood Coagulation Factors
4
2000
50
0.170
Why?
Magnetic Resonance Angiography
1
2010
35
0.170
Why?
Acute Coronary Syndrome
1
2009
7
0.170
Why?
Radiation Dosage
1
2010
115
0.170
Why?
Critical Care
1
2010
64
0.170
Why?
Germany
4
2005
26
0.160
Why?
Happiness
1
2009
10
0.160
Why?
Silicones
1
2009
27
0.160
Why?
Statistics as Topic
3
2001
177
0.160
Why?
Tachycardia
2
1986
64
0.160
Why?
Hemostasis, Surgical
1
2008
12
0.160
Why?
Apolipoprotein A-I
1
2008
23
0.160
Why?
Lipase
1
2008
16
0.160
Why?
Lipoprotein(a)
1
2008
15
0.160
Why?
Punctures
1
2008
25
0.160
Why?
Double-Blind Method
2
2005
985
0.160
Why?
Hypercholesterolemia
2
2005
40
0.160
Why?
Coronary Angiography
3
1998
78
0.160
Why?
Coagulants
1
2008
13
0.160
Why?
Conserved Sequence
1
2009
102
0.160
Why?
Acetanilides
1
2008
9
0.160
Why?
Vagus Nerve
1
2008
39
0.160
Why?
Asian Continental Ancestry Group
1
2008
29
0.150
Why?
Chromatography, High Pressure Liquid
3
2002
206
0.150
Why?
Diagnostic Errors
1
2009
87
0.150
Why?
Femoral Artery
1
2008
80
0.150
Why?
Siblings
1
2008
35
0.150
Why?
Delayed Rectifier Potassium Channels
1
2008
10
0.150
Why?
Triglycerides
2
2003
95
0.150
Why?
Atrial Flutter
1
2008
24
0.150
Why?
Coronary Stenosis
2
2004
7
0.150
Why?
Cost-Benefit Analysis
2
2005
200
0.150
Why?
Fractals
3
2001
7
0.150
Why?
Catheter Ablation
1
2009
72
0.150
Why?
Medical History Taking
1
2008
59
0.150
Why?
Discriminant Analysis
1
2007
21
0.150
Why?
Piperazines
1
2008
71
0.150
Why?
Postoperative Complications
2
2001
706
0.150
Why?
Quality of Life
2
2007
486
0.150
Why?
African Americans
1
2010
209
0.150
Why?
Sodium
1
2008
296
0.140
Why?
Europe
3
2011
74
0.140
Why?
Aryldialkylphosphatase
1
2007
5
0.140
Why?
Pregnancy, High-Risk
1
2007
10
0.140
Why?
Natriuretic Peptide, Brain
1
2007
10
0.140
Why?
Platelet Glycoprotein GPIb-IX Complex
1
2007
5
0.140
Why?
Hypolipidemic Agents
2
2002
15
0.140
Why?
Cardiac Output, Low
1
2007
16
0.140
Why?
Patient Education as Topic
2
2005
207
0.140
Why?
Aging
2
1998
692
0.140
Why?
International Normalized Ratio
1
2006
8
0.140
Why?
E-Selectin
1
2006
17
0.140
Why?
Kidney
1
2010
581
0.140
Why?
Hemorrhage
1
2008
173
0.140
Why?
Vehicle Emissions
1
2007
23
0.140
Why?
Diabetic Angiopathies
1
2007
31
0.140
Why?
NADPH Oxidase
1
2007
30
0.140
Why?
Point Mutation
2
2003
169
0.140
Why?
User-Computer Interface
1
2007
40
0.140
Why?
Radiotherapy, High-Energy
1
2006
22
0.140
Why?
Health Knowledge, Attitudes, Practice
1
2010
247
0.140
Why?
Threonine
1
2006
25
0.140
Why?
Nitric Oxide Synthase Type III
1
2007
64
0.140
Why?
Methionine
1
2006
52
0.140
Why?
Education, Medical, Continuing
1
2007
65
0.140
Why?
Protein Precursors
1
2007
82
0.140
Why?
Homozygote
1
2006
91
0.140
Why?
Rest
1
2006
21
0.130
Why?
Surgical Procedures, Elective
1
2006
32
0.130
Why?
Outcome Assessment (Health Care)
2
2005
275
0.130
Why?
Health Personnel
1
2006
57
0.130
Why?
Electrophysiologic Techniques, Cardiac
1
2005
23
0.130
Why?
Arousal
2
2000
54
0.130
Why?
Stress, Psychological
1
2009
264
0.130
Why?
Pregnancy Outcome
1
2007
136
0.130
Why?
Paper
1
2005
8
0.130
Why?
Information Storage and Retrieval
1
2005
26
0.130
Why?
Poland
1
2005
12
0.130
Why?
Intercellular Adhesion Molecule-1
1
2006
124
0.130
Why?
Apolipoproteins B
2
2000
174
0.130
Why?
Dehydroepiandrosterone Sulfate
1
2005
7
0.130
Why?
Epidemiologic Studies
1
2005
19
0.130
Why?
Insulin
3
1999
626
0.130
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
43
0.120
Why?
Zinc Oxide
1
2005
7
0.120
Why?
Follicle Stimulating Hormone
1
2005
49
0.120
Why?
Medical Records Systems, Computerized
1
2005
36
0.120
Why?
Peptide Fragments
1
2007
277
0.120
Why?
Diabetes Complications
1
2005
60
0.120
Why?
Molecular Sequence Data
3
2002
1993
0.120
Why?
Contrast Media
1
2007
269
0.120
Why?
Heart Rupture, Post-Infarction
1
2004
1
0.120
Why?
Prostheses and Implants
1
2005
82
0.120
Why?
Amino Acid Sequence
2
2003
1198
0.120
Why?
Software
1
2005
126
0.120
Why?
Postoperative Period
1
2004
78
0.120
Why?
Sympathectomy
1
2004
21
0.120
Why?
Intermittent Claudication
1
2004
10
0.120
Why?
Heterozygote Detection
2
1999
23
0.110
Why?
Primary Health Care
1
2008
449
0.110
Why?
Genes, Recessive
1
2003
38
0.110
Why?
Endpoint Determination
1
2003
31
0.110
Why?
Thioridazine
1
2003
1
0.110
Why?
Risk Sharing, Financial
1
2003
3
0.110
Why?
Estradiol
1
2004
195
0.110
Why?
Hyperlipidemias
1
2003
43
0.110
Why?
Benzodiazepines
1
2003
22
0.110
Why?
Drug Labeling
1
2003
12
0.110
Why?
Dopamine Antagonists
1
2003
22
0.110
Why?
Atropine
1
2002
32
0.100
Why?
Apolipoproteins
4
2000
41
0.100
Why?
Lipoproteins, HDL
2
1997
33
0.100
Why?
Androgens
1
2004
139
0.100
Why?
History, 20th Century
2
1991
232
0.100
Why?
Exercise Test
3
1994
88
0.100
Why?
United States Food and Drug Administration
1
2002
42
0.100
Why?
Leukocyte Count
1
2001
152
0.100
Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2001
3
0.100
Why?
Hyperhomocysteinemia
1
2001
3
0.100
Why?
Blood Proteins
1
2001
94
0.090
Why?
Endothelium, Vascular
2
2001
401
0.090
Why?
Gene Expression Profiling
1
2003
296
0.090
Why?
World Health
2
2011
59
0.090
Why?
Sex Characteristics
2
1998
138
0.090
Why?
Cardiolipins
1
2000
8
0.090
Why?
Models, Molecular
3
2002
350
0.090
Why?
Longitudinal Studies
2
1997
372
0.090
Why?
Diabetes Mellitus, Type 1
1
2001
162
0.090
Why?
Electroencephalography
1
2000
133
0.090
Why?
Autoantibodies
1
2000
109
0.090
Why?
Latex Fixation Tests
1
1999
20
0.090
Why?
Swimming
1
1999
7
0.090
Why?
Questionnaires
1
2005
942
0.090
Why?
Amino Acid Substitution
2
2007
118
0.080
Why?
Polymorphism, Single-Stranded Conformational
3
2002
38
0.080
Why?
Acoustic Stimulation
1
1999
170
0.080
Why?
Creatinine
2
2007
128
0.080
Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
2
2006
16
0.080
Why?
Physicians, Family
2
2008
98
0.070
Why?
Codon, Nonsense
2
2007
54
0.070
Why?
Models, Animal
2
2006
131
0.070
Why?
Systole
2
2005
38
0.070
Why?
Lipoproteins, LDL
1
1997
31
0.070
Why?
Membrane Potentials
2
2007
338
0.070
Why?
Phospholipases A2
2
2006
27
0.070
Why?
Sleep
2
2001
56
0.070
Why?
Family Health
3
1998
84
0.070
Why?
Rabbits
2
2006
686
0.070
Why?
Action Potentials
2
1990
248
0.070
Why?
Amiodarone
2
2002
9
0.070
Why?
Cerebrovascular Disorders
1
1997
111
0.070
Why?
Chromosomes, Human, Pair 7
1
1995
19
0.070
Why?
Chromosomes, Human, Pair 3
1
1995
18
0.070
Why?
Chromosomes, Human, Pair 11
1
1995
29
0.060
Why?
Life Tables
2
2004
35
0.060
Why?
Family
2
2001
198
0.060
Why?
Pregnancy
3
1998
1919
0.060
Why?
Administration, Inhalation
2
2005
171
0.060
Why?
Genetic Markers
2
2003
127
0.060
Why?
Suicide, Attempted
1
1997
202
0.060
Why?
Sputum
2
2004
38
0.060
Why?
Nitric Oxide
2
2004
239
0.060
Why?
Metoprolol
2
2000
10
0.050
Why?
Atenolol
2
2000
12
0.050
Why?
Blood Coagulation
2
2000
66
0.050
Why?
Animals
4
2006
15647
0.050
Why?
Sequence Analysis, DNA
2
2002
161
0.050
Why?
Genetic Association Studies
1
2011
17
0.050
Why?
Nonlinear Dynamics
2
2001
35
0.050
Why?
Precipitating Factors
1
2011
5
0.050
Why?
Glucose Intolerance
1
2011
21
0.050
Why?
Genome-Wide Association Study
1
2011
22
0.050
Why?
Glucose Tolerance Test
1
2011
68
0.050
Why?
Estrogen Replacement Therapy
1
2011
21
0.050
Why?
RNA, Messenger
2
2006
1791
0.050
Why?
Echocardiography, Doppler
1
2011
48
0.050
Why?
Environmental Monitoring
1
2011
62
0.050
Why?
Computers, Handheld
1
2010
9
0.050
Why?
Minnesota
1
2010
22
0.050
Why?
Atmosphere
1
2010
1
0.050
Why?
National Institutes of Health (U.S.)
2
2001
60
0.050
Why?
Climate
1
2010
4
0.050
Why?
Polymerase Chain Reaction
2
2003
586
0.050
Why?
Blood Volume
1
2010
51
0.050
Why?
Endocardium
1
2010
9
0.040
Why?
Desmosomes
1
2010
4
0.040
Why?
Oocytes
1
2011
134
0.040
Why?
Temperature
1
2010
239
0.040
Why?
Xenopus laevis
1
2011
168
0.040
Why?
Models, Statistical
1
2011
222
0.040
Why?
Protein Structure, Secondary
1
2009
84
0.040
Why?
Obesity, Morbid
1
2010
49
0.040
Why?
Dose-Response Relationship, Radiation
1
2010
205
0.040
Why?
Causality
1
2009
43
0.040
Why?
Early Ambulation
1
2008
5
0.040
Why?
Angiography
1
2009
89
0.040
Why?
Computer Simulation
1
2011
295
0.040
Why?
Health Care Surveys
1
2010
139
0.040
Why?
Fibrinogen
2
1999
149
0.040
Why?
Continental Population Groups
1
2010
116
0.040
Why?
Administration, Topical
1
2008
88
0.040
Why?
Decision Support Systems, Clinical
1
2008
22
0.040
Why?
Pressure
1
2008
126
0.040
Why?
Interviews as Topic
1
2009
157
0.040
Why?
Computational Biology
1
2009
66
0.040
Why?
Minority Groups
1
2008
52
0.040
Why?
Oscillometry
1
2008
24
0.040
Why?
Chromosome Mapping
2
1995
223
0.040
Why?
Genetic Linkage
2
1995
150
0.040
Why?
Patient Satisfaction
1
2009
216
0.040
Why?
Frameshift Mutation
1
2007
21
0.040
Why?
RNA Splice Sites
1
2007
15
0.040
Why?
Netherlands
1
2007
28
0.040
Why?
Mutagenesis, Insertional
1
2007
52
0.040
Why?
Ion Transport
1
2007
69
0.040
Why?
Postpartum Period
1
2007
37
0.040
Why?
Rats, Inbred SHR
1
2007
43
0.040
Why?
Sulfur Dioxide
1
2006
11
0.030
Why?
Injections, Intraperitoneal
1
2007
82
0.030
Why?
Glutamine
1
2007
62
0.030
Why?
Aspartic Acid
1
2007
45
0.030
Why?
Parity
1
2007
47
0.030
Why?
Patient Readmission
1
2007
39
0.030
Why?
Telemetry
1
2007
24
0.030
Why?
Aerosols
1
2007
115
0.030
Why?
Carbon Monoxide
1
2006
53
0.030
Why?
Internationality
1
2006
22
0.030
Why?
Arginine
1
2007
107
0.030
Why?
Automobile Driving
1
2007
32
0.030
Why?
Nitrous Oxide
1
2006
40
0.030
Why?
Glutamic Acid
1
2007
95
0.030
Why?
Protein Transport
1
2007
160
0.030
Why?
Enzyme Inhibitors
1
2008
396
0.030
Why?
Models, Cardiovascular
1
2006
67
0.030
Why?
Gap Junctions
1
2006
58
0.030
Why?
Potassium
1
2007
303
0.030
Why?
Nebraska
1
2005
6
0.030
Why?
Gestational Age
1
2007
334
0.030
Why?
Database Management Systems
1
2005
12
0.030
Why?
Propanolamines
1
2005
11
0.030
Why?
Placebo Effect
1
2005
36
0.030
Why?
Carbazoles
1
2005
27
0.030
Why?
Artificial Intelligence
1
2005
22
0.030
Why?
Protein Structure, Tertiary
1
2007
347
0.030
Why?
Lipopolysaccharides
1
2007
208
0.030
Why?
Length of Stay
1
2007
284
0.030
Why?
Equipment Failure Analysis
1
2005
68
0.030
Why?
Massachusetts
1
2005
28
0.030
Why?
Advisory Committees
1
2005
17
0.030
Why?
Smoking Cessation
1
2006
77
0.030
Why?
Radiotherapy
1
2006
179
0.030
Why?
Lymphocyte Subsets
1
2004
28
0.030
Why?
Respiratory System
1
2005
42
0.030
Why?
Heart Atria
1
2005
62
0.030
Why?
Cardiovascular System
1
2004
47
0.030
Why?
Ganglionectomy
1
2004
7
0.030
Why?
Blotting, Western
1
2006
617
0.030
Why?
Respiration
1
2004
176
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2006
513
0.030
Why?
Blood Chemical Analysis
1
2003
37
0.030
Why?
Factor Analysis, Statistical
1
2003
56
0.030
Why?
Diseases in Twins
1
2003
39
0.030
Why?
Rare Diseases
1
2003
27
0.030
Why?
Oxidative Stress
1
2007
330
0.030
Why?
Immunohistochemistry
1
2006
1024
0.030
Why?
Clinical Protocols
1
2003
102
0.030
Why?
Nucleic Acid Denaturation
1
2003
49
0.030
Why?
Entropy
1
2002
8
0.030
Why?
Exons
1
2003
165
0.030
Why?
Introns
1
2003
112
0.030
Why?
Hearing Loss, Sensorineural
1
2002
19
0.030
Why?
Principal Component Analysis
1
2001
28
0.020
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2001
5
0.020
Why?
Mexiletine
1
2001
12
0.020
Why?
Drug Monitoring
1
2001
39
0.020
Why?
Cytokines
1
2004
555
0.020
Why?
beta 2-Glycoprotein I
1
2000
4
0.020
Why?
Mitral Valve Insufficiency
1
2000
20
0.020
Why?
Immunoglobulin M
1
2000
146
0.020
Why?
Administration, Oral
1
2001
302
0.020
Why?
Nadolol
1
2000
5
0.020
Why?
Propranolol
1
2000
81
0.020
Why?
Bias (Epidemiology)
1
2000
41
0.020
Why?
Automation
1
1999
31
0.020
Why?
Binding Sites
1
2002
688
0.020
Why?
Factor VII
1
1999
7
0.020
Why?
Pilot Projects
1
2001
426
0.020
Why?
Factor VIIa
1
1999
15
0.020
Why?
Evaluation Studies as Topic
1
1999
240
0.020
Why?
Chronic Disease
1
2001
496
0.020
Why?
Glycoproteins
1
2000
189
0.020
Why?
Rats
1
2007
4185
0.020
Why?
Stress, Physiological
1
2000
102
0.020
Why?
Immunoglobulin G
1
2000
491
0.020
Why?
Acute Disease
1
2000
570
0.020
Why?
Abortion, Induced
1
1998
46
0.020
Why?
Base Sequence
1
2002
1681
0.020
Why?
Thallium Radioisotopes
1
1997
13
0.020
Why?
Gene Expression
1
2000
723
0.020
Why?
Arrhythmia, Sinus
1
1995
7
0.020
Why?

Visualizations


Zareba's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department